# Adjuvant Valproate for High Grade Sarcomas

> **NCT01010958** · PHASE1 · TERMINATED · sponsor: **Columbia University** · enrollment: 7 (actual)

## Conditions studied

- High Grade Sarcoma

## Interventions

- **DRUG:** Valproic Acid

## Key facts

- **NCT ID:** NCT01010958
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-10
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2015-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01010958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01010958, "Adjuvant Valproate for High Grade Sarcomas". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01010958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*